HELSINKI, April 27 (Reuters) - Finnish drug maker Orion
on Wednesday reported better than expected quarterly
results as revenue from its asthma treatment products helped
offset falling sales of its Parkinson's disease drug which faced
increased generic competition.
Read more
No comments:
Post a Comment